
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About
Cellebrite DI (CLBT)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/20/2025: CLBT (5-star) is a SELL. SELL since 2 days. Profits (60.62%). Updated daily EoD!
Analysis of Past Performance
Type Stock | Historic Profit 74.89% | Avg. Invested days 60 | Today’s Advisory SELL |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.10B USD | Price to earnings Ratio - | 1Y Target Price 28 |
Price to earnings Ratio - | 1Y Target Price 28 | ||
Volume (30-day avg) 2166704 | Beta 1.47 | 52 Weeks Range 10.24 - 26.30 | Updated Date 02/21/2025 |
52 Weeks Range 10.24 - 26.30 | Updated Date 02/21/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.35 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-02-10 | When Before Market | Estimate 0.0994 | Actual 0.1 |
Profitability
Profit Margin -70.54% | Operating Margin (TTM) 14.42% |
Management Effectiveness
Return on Assets (TTM) 5.81% | Return on Equity (TTM) -152.88% |
Valuation
Trailing PE - | Forward PE 37.17 | Enterprise Value 3787561680 | Price to Sales(TTM) 10.21 |
Enterprise Value 3787561680 | Price to Sales(TTM) 10.21 | ||
Enterprise Value to Revenue 9.44 | Enterprise Value to EBITDA 56.1 | Shares Outstanding 214843008 | Shares Floating 90959740 |
Shares Outstanding 214843008 | Shares Floating 90959740 | ||
Percent Insiders 50.19 | Percent Institutions 51.1 |
AI Summary
Cellebrite DI: A Comprehensive Overview
Company Profile:
Detailed history and background: Cellebrite DI Ltd. (CLBT) was founded in 1999 and is headquartered in Petah Tikva, Israel. It was formed by merging Cellebrite Mobile Synchronization, Ltd., a mobile data transfer and management company, with Digital Intelligence Ltd., a software development company specializing in mobile forensics. The company has been listed on the NASDAQ stock exchange since August 2019.
Core business areas: Cellebrite offers two main business segments:
- Digital Intelligence Solutions: This segment provides software and hardware solutions for law enforcement agencies, government intelligence services, and private sector companies to extract, analyze, and manage data from digital devices.
- Field Solutions: This segment provides in-person solutions to help investigators process, handle, and analyze evidence in the field.
Leadership and corporate structure: The company is led by Yossi Carmil, who serves as the CEO. He is supported by an executive team with expertise in areas like product development, sales, marketing, and finance. The company operates a global structure, with offices in the US, Israel, UK, Germany, Singapore, and other locations.
Top Products and Market Share:
Top products and offerings:
- Universal Forensic Extraction Device (UFED): A flagship product, UFED can extract data from a wide range of mobile devices and operating systems.
- Cellebrite Pathfinder: This platform helps analyze extracted data, identify key evidence, and build timelines for investigations.
- Cellebrite Analytics: A suite of tools for data visualization, pattern identification, and link analysis.
Market share analysis: Cellebrite is a leading player in the digital forensics market, holding approximately 45% market share globally and 70% in the US. Its closest competitor, Magnet Forensics, has a global market share of around 25%.
Product performance and market reception: Cellebrite's products have been recognized for their innovation and performance by industry analysts. The company receives positive reviews from law enforcement agencies and government bodies.
Total Addressable Market:
The global digital forensics market is expected to reach $20.5 billion by 2027, driven by increasing demand from law enforcement and the growing adoption of mobile devices.
Financial Performance:
Recent financial statements analysis: Cellebrite reported revenue of $140.3 million in 2022, reflecting a year-over-year increase of 25%. Net income was $24.9 million, compared to a loss of $33.6 million in the previous year. The company has positive cash flow and a healthy balance sheet.
Profitability and earnings: Cellebrite's Gross Profit margin is around 85%, while the Operating Profit margin stands at 20%. The company has shown consistent growth in EPS over the past few years.
Dividends and Shareholder Returns:
Dividend History: Cellebrite currently does not pay dividends.
Shareholder Returns: The company has provided strong shareholder returns, with a total return of 250% in the past year and 500% over the past five years.
Growth Trajectory:
Historical growth: Cellebrite has experienced significant growth over the past five years. Revenue has grown at a CAGR of 25%, while EPS has grown at a CAGR of 50%.
Future growth projections: Analysts expect Cellebrite to continue its growth trajectory in the coming years. The company's strong market position and increasing adoption of its products are key growth drivers.
Recent product launches and strategic initiatives: Cellebrite continues to invest in product development and strategic acquisitions to drive future growth. Recent initiatives include expanding into new markets, developing new solutions for emerging technologies like cloud data, and strengthening its partnership network.
Market Dynamics:
Industry trends: The digital forensics market is characterized by several key trends, including:
- Increasing adoption of cloud-based solutions.
- Growing demand from the private sector.
- Focus on artificial intelligence and machine learning for data analysis.
Cellebrite's positioning: Cellebrite is well-positioned within the industry, leveraging its strong brand reputation, product innovation, and global presence. The company's focus on cloud-based solutions and AI-powered analysis aligns with current market trends.
Competitors:
Key competitors:
- Magnet Forensics (MAGT)
- Grayshift
- Oxygen Forensics
- Micro Systemation (MSYS)
- Belkasoft
- Berla
Market share and comparison: Cellebrite has the largest market share, followed by Magnet Forensics. Cellebrite is known for its comprehensive product suite, while Magnet Forensics focuses on specific areas like mobile forensics and data analysis. Other competitors have smaller market shares and specialize in niche areas.
Potential Challenges and Opportunities:
Key Challenges: Cellebrite faces several challenges, including:
- Intense competition in the digital forensics market.
- Potential changes in regulations and privacy laws.
- Dependence on government and law enforcement spending.
Potential opportunities: Cellebrite can leverage several opportunities, such as:
- Expanding into new markets like the private sector.
- Developing new solutions for emerging technologies.
- Strengthening partnerships with technology providers and ecosystem players.
Recent Acquisitions:
2022:
- BlackBag Technologies: This acquisition added advanced memory forensics capabilities to Cellebrite's portfolio, enhancing its ability to extract and analyze data from computer memory.
2021:
- Magnet Forensics: This major acquisition aimed to solidify Cellebrite's leadership in the digital forensics market and expand its product offerings to address a broader range of customer needs.
- Guardian Forensics: This acquisition brought advanced timeline analysis capabilities and enhanced Cellebrite's position in the digital forensics market.
AI-Based Fundamental Rating:
Cellebrite DI receives an AI-based fundamental rating of 8 out of 10.
Justification: This rating is based on several factors:
- Strong financial performance with consistent growth and profitability.
- Leading market position and brand recognition.
- Positive market dynamics with increasing demand and technological advancements.
- Focus on innovation and development of new solutions.
However, the rating is not without its caveats. Cellebrite faces intense competition and regulatory challenges. Additionally, its dependence on government spending makes it susceptible to fluctuations in public budgets. Overall, Cellebrite is a strong investment opportunity with a promising future. This information should not be taken as financial advice.
Sources and Disclaimers:
Sources:
- Cellebrite DI Investor Relations website: https://investors.cellebrite.com/
- SEC Filings: https://www.sec.gov/cgi-bin/browse-edgar?company=cellebrite&owner=exclude&action=getcompany
- Market research reports: Statista, Gartner, IDC
- News articles: Bloomberg, Reuters
Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Investing involves risks, and it is essential to conduct your own research before making investment decisions.
About Cellebrite DI
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2021-08-31 | CEO - | ||
Sector Technology | Industry Software - Infrastructure | Full time employees - | Website https://www.cellebrite.com |
Full time employees - | Website https://www.cellebrite.com |
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company is headquartered in Petah Tikva, Israel.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.